According to Catalyst Pharmaceuticals's latest financial reports the company has $0.38 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.38 B | 29.11% |
2022-12-31 | $0.30 B | 45.25% |
2021-12-31 | $0.20 B | 21.95% |
2020-12-31 | $0.16 B | 93.54% |
2019-12-31 | $87.62 M | 72.55% |
2018-12-31 | $50.78 M | -37.28% |
2017-12-31 | $80.96 M | 105.97% |
2016-12-31 | $39.3 M | -29.14% |
2015-12-31 | $55.47 M | 57.41% |
2014-12-31 | $35.24 M | 64.75% |
2013-12-31 | $21.39 M | 46.29% |
2012-12-31 | $14.62 M | 288.81% |
2011-12-31 | $3.76 M | -31.84% |
2010-12-31 | $5.51 M | -27.57% |
2009-12-31 | $7.61 M | -27.86% |
2008-12-31 | $10.56 M | -35.3% |
2007-12-31 | $16.32 M | -17.76% |
2006-12-31 | $19.84 M | 4345.31% |
2005-12-31 | $0.44 M | 279.72% |
2004-12-31 | $0.11 M | |
2002-12-31 | $0.04 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 17,630.70% | ๐บ๐ธ USA |
Pfizer PFE | $89.28 B | 22,919.43% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $38.82 B | 9,910.03% | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | $0.85 B | 121.55% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $58.95 M | -84.80% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $4.95 B | 1,176.56% | ๐บ๐ธ USA |